Home › Funds › Point72 Asset Management › ACRS
Point72 Asset Management position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Latest position (Q4 2025)87.17K sh
Reported value held$262.40K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 391.30K | $7.04M | New |
| Q4 2021 | 642.90K | $9.35M | Add |
| Q1 2022 | 2.28M | $39.26M | Add |
| Q2 2022 | 1.73M | $24.20M | Reduce |
| Q3 2022 | 1.85M | $29.17M | Add |
| Q4 2022 | 1.78M | $28.08M | Reduce |
| Q1 2023 | 1.34M | $10.88M | Reduce |
| Q2 2023 | 1.74M | $18.01M | Add |
| Q3 2023 | 662.53K | $4.54M | Reduce |
| Q4 2025 | 87.17K | $262.40K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ACRS
- BlackRock Inc 10.04M sh · $53.10M · Q2 2026
- Vanguard Group 6.50M sh · $19.57M · Q4 2025
- Geode Capital Management 3.19M sh · $16.88M · Q2 2026
- Balyasny Asset Management 2.02M sh · $10.70M · Q2 2026
- Deutsche Bank AG 1.04M sh · $5.51M · Q2 2026
- Northern Trust Corp 998.76K sh · $5.28M · Q2 2026
- Renaissance Technologies 817.53K sh · $4.32M · Q2 2026
- Goldman Sachs Group 609.16K sh · $3.22M · Q2 2026
- Millennium Management 523.89K sh · $2.77M · Q2 2026
- JPMorgan Chase & Co 468.96K sh · $2.35M · Q2 2026
- D. E. Shaw & Co 414.50K sh · $2.19M · Q2 2026
- Charles Schwab Investment Management 346.06K sh · $1.83M · Q2 2026